Key points are not available for this paper at this time.
We are still at an early stage of assessing oxytocin-based therapy for autism spectrum disorders
Young et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: